FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ZNF587B-AURKC

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ZNF587B-AURKC
FusionPDB ID: 102465
FusionGDB2.0 ID: 102465
HgeneTgene
Gene symbol

ZNF587B

AURKC

Gene ID

100293516

6795

Gene namezinc finger protein 587Baurora kinase C
Synonyms-AIE2|AIK3|ARK3|AurC|HEL-S-90|SPGF5|STK13|aurora-C
Cytomap

19q13.43

19q13.43

Type of geneprotein-codingprotein-coding
Descriptionzinc finger protein 587Baurora kinase CARK-3aurora 3aurora-related kinase 3aurora/IPL1-related kinase 3aurora/IPL1/EG2 protein 2epididymis secretory protein Li 90serine/threonine kinase 13 (aurora/IPL1-like)serine/threonine-protein kinase 13serine/threonine-protein kina
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000316462, ENST00000442832, 
ENST00000594901, 
ENST00000302804, 
ENST00000448930, ENST00000598785, 
ENST00000599062, ENST00000415300, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score12 X 7 X 7=5885 X 4 X 3=60
# samples 145
** MAII scorelog2(14/588*10)=-2.0703893278914
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(5/60*10)=-0.263034405833794
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ZNF587B [Title/Abstract] AND AURKC [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ZNF587B [Title/Abstract] AND AURKC [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ZNF587B(58350517)-AURKC(57743110), # samples:1
Anticipated loss of major functional domain due to fusion event.ZNF587B-AURKC seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ZNF587B-AURKC seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ZNF587B-AURKC seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ZNF587B-AURKC seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneAURKC

GO:0006468

protein phosphorylation

15670791



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:58350517/chr19:57743110)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ZNF587B (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across AURKC (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000316462ZNF587Bchr1958350517+ENST00000415300AURKCchr1957743110+12143421251213363
ENST00000442832ZNF587Bchr1958350517+ENST00000415300AURKCchr1957743110+12693971141268384
ENST00000594901ZNF587Bchr1958350517+ENST00000415300AURKCchr1957743110+1251379961250384

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000316462ENST00000415300ZNF587Bchr1958350517+AURKCchr1957743110+0.0040497020.9959502
ENST00000442832ENST00000415300ZNF587Bchr1958350517+AURKCchr1957743110+0.00497380.9950262
ENST00000594901ENST00000415300ZNF587Bchr1958350517+AURKCchr1957743110+0.0058707260.9941293

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ZNF587B-AURKC

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ZNF587Bchr1958350517AURKCchr195774311034272DVTLENLALMSSLVATANQTAQQPSS
ZNF587Bchr1958350517AURKCchr195774311037994DVTLENLALMSSLVATANQTAQQPSS
ZNF587Bchr1958350517AURKCchr195774311039794DVTLENLALMSSLVATANQTAQQPSS

Top

Potential FusionNeoAntigen Information of ZNF587B-AURKC in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ZNF587B-AURKC_58350517_57743110.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:22ALMSSLVAT0.98470.565716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:27ALMSSLVAT0.97710.662716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:13ALMSSLVAT0.97580.748716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:60ALMSSLVAT0.97520.503716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:38ALMSSLVAT0.94750.6903716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:19ALMSSLVAT0.93610.5286716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:13ALMSSLVATA0.99720.703717
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:27ALMSSLVATA0.99630.6154717
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:38ALMSSLVATA0.99330.6885717
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:03LMSSLVATA0.99730.7169817
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:03ALMSSLVAT0.98730.6407716
ZNF587B-AURKCchr1958350517chr1957743110342HLA-A02:03ALMSSLVATA0.99870.6182717

Top

Potential FusionNeoAntigen Information of ZNF587B-AURKC in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ZNF587B-AURKC_58350517_57743110.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0403MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0403LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0407MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0413MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0413LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0413SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0415MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0422MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0427MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0427LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0427SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0431MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0436MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0437MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0438MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0439MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0439LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0440MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0440LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0441MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0441LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0442MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0444MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0444LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0444SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0446MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0446LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0449MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0449LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0449SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0450MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0450LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0451MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0451LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0451SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0452MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0452LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0453MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0455MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0455LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0455SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0456MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0456LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0458MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0459MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0460MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0460LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0465MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0465LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0468MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0468LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0470MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0470LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0471MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0471LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0473MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0473LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0474MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0475MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0478MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0478LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0478SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0478ALMSSLVATANQTAQ722
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0479MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0479LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0485MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0485LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0488MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-0488LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-1410MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-1410LMSSLVATANQTAQQ823
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-1410SSLVATANQTAQQPS1025
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-1457MSSLVATANQTAQQP924
ZNF587B-AURKCchr1958350517chr1957743110342DRB1-1615MSSLVATANQTAQQP924

Top

Fusion breakpoint peptide structures of ZNF587B-AURKC

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4765LALMSSLVATANQTZNF587BAURKCchr1958350517chr1957743110342

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ZNF587B-AURKC

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4765LALMSSLVATANQT-7.15543-7.26883
HLA-B14:023BVN4765LALMSSLVATANQT-4.77435-5.80965
HLA-B52:013W394765LALMSSLVATANQT-6.80875-6.92215
HLA-B52:013W394765LALMSSLVATANQT-4.20386-5.23916
HLA-A11:014UQ24765LALMSSLVATANQT-7.5194-8.5547
HLA-A11:014UQ24765LALMSSLVATANQT-6.9601-7.0735
HLA-A24:025HGA4765LALMSSLVATANQT-7.52403-7.63743
HLA-A24:025HGA4765LALMSSLVATANQT-5.82433-6.85963
HLA-B27:056PYJ4765LALMSSLVATANQT-3.28285-4.31815
HLA-B44:053DX84765LALMSSLVATANQT-5.91172-6.94702
HLA-B44:053DX84765LALMSSLVATANQT-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of ZNF587B-AURKC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ZNF587B-AURKCchr1958350517chr1957743110716ALMSSLVATCACTTATGTCCTCCCTGGTGGCTACAG
ZNF587B-AURKCchr1958350517chr1957743110717ALMSSLVATACACTTATGTCCTCCCTGGTGGCTACAGCAA
ZNF587B-AURKCchr1958350517chr1957743110817LMSSLVATATTATGTCCTCCCTGGTGGCTACAGCAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ZNF587B-AURKCchr1958350517chr19577431101025SSLVATANQTAQQPSCCTCCCTGGTGGCTACAGCAAACCAAACAGCCCAGCAGCCCAGCA
ZNF587B-AURKCchr1958350517chr1957743110722ALMSSLVATANQTAQCACTTATGTCCTCCCTGGTGGCTACAGCAAACCAAACAGCCCAGC
ZNF587B-AURKCchr1958350517chr1957743110823LMSSLVATANQTAQQTTATGTCCTCCCTGGTGGCTACAGCAAACCAAACAGCCCAGCAGC
ZNF587B-AURKCchr1958350517chr1957743110924MSSLVATANQTAQQPTGTCCTCCCTGGTGGCTACAGCAAACCAAACAGCCCAGCAGCCCA

Top

Information of the samples that have these potential fusion neoantigens of ZNF587B-AURKC

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCECZNF587B-AURKCchr1958350517ENST00000316462chr1957743110ENST00000415300TCGA-PG-A914

Top

Potential target of CAR-T therapy development for ZNF587B-AURKC

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ZNF587B-AURKC

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ZNF587B-AURKC

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource